financetom
Business
financetom
/
Business
/
Belden Insider Sold Shares Worth $386,469, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Belden Insider Sold Shares Worth $386,469, According to a Recent SEC Filing
Nov 12, 2024 10:52 AM

01:20 PM EST, 11/12/2024 (MT Newswires) -- Doug Zink, Vice President and Chief Accounting Officer, on November 07, 2024, sold 3,000 shares in Belden (BDC) for $386,469. Following the Form 4 filing with the SEC, Zink has control over a total of 7,642 shares of the company, with 6,643 shares held directly and 999 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/913142/000095017024125043/xslF345X05/ownership.xml

Price: 123.99, Change: -2.62, Percent Change: -2.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates
May 10, 2024
11:27 AM EDT, 05/10/2024 (MT Newswires) -- Biohaven ( BHVN ) shares were falling past 11% in recent Friday trading after the company reported a Q1 adjusted net loss that missed analysts' estimates. The biopharmaceutical company reported a Q1 adjusted net loss late Thursday of $1.77 per diluted share, wider than a loss of $0.98 a year earlier. Two analysts...
Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates
Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates
May 10, 2024
11:25 AM EDT, 05/10/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Iovance Biotherapeutics' ( IOVA ) shares fell 16% in recent Friday trading, a day after the company's Q1 revenue trailed estimates by analysts. The company reported a Q1 net loss late Thursday of $0.42 per diluted share, narrower than...
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi
May 10, 2024
11:25 AM EDT, 05/10/2024 (MT Newswires) -- Shares of Novavax ( NVAX ) more than doubled intraday Friday after the company announced a licensing agreement with French drugmaker Sanofi ( SNY ) to co-commercialize the former's adjuvanted COVID-19 vaccine and develop combination vaccines that also protect against influenza. Novavax ( NVAX ) will receive a $500 million upfront payment and...
US CFTC seeks to ban derivatives bets on elections, calamities
US CFTC seeks to ban derivatives bets on elections, calamities
May 10, 2024
NEW YORK (Reuters) - The U.S. Commodity Futures Trading Commission (CFTC) on Friday was poised to propose a ban on listed derivatives used to bet on U.S. elections and other major real world events, its chair said. The agency is scheduled to vote on Friday on the proposed regulations which would ban the listing and clearing of so-called event contracts,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved